IPO of Bone Therapeutics plc

Target Company Name:
Country:
Advisory:
Sector:
Partner:
Bone Therapeutics plc
Belgium Luxembourg
Advisor
Healthcare & Pharmaceuticals
Zeus

Zeus Capital advises on first European listing. Zeus Capital has acted as co-manager to Bone Therapeutics on its €32.2m Euronext Brussels and Euronext Paris IPO.

Bone Therapeutics plc
Belgium Based - Bone Therapeutics (BOTHE) Market: Euronext Brussels, Paris €105 million market cap
logo
Advisor :
Zeus

Relevant transactions

Transactions
Project Amygdala
Private Equity
Sale of mental health services provider for high-acuity individuals in the UK
logo
Advisor to the seller :
Cooper Parry Corporate Finance
Genbio
Private Investors
Sale of a minority stake of Genbio, a hemoderivatives producer, to Private Investors
logo
Advisor to the seller :
RIóN
icotec
MVM Partners
icotec, the world leader in the field of spinal tumor implants, has closed its USD 30m growth financing round led by MVM
logo
Advisor
Alpha Source Group
Probo Medical
Alpha Source Group, a portfolio company of Baird Capital, acquired by Probo Medical.
logo
Advisor to the seller :
Brown Gibbons Lang & Company

REACH Cross-Border Mergers & Acquisitions is a worldwide partnership of 24 M&A advisory firms operating across 30 countries.

REACH Cross-Border Mergers & Acquisitions Logo with tagline Terms & Conditions
Privacy Policy

© 2024 REACH Cross-Border Mergers & Acquisitions